Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
10.15
+0.13 (1.30%)
At close: Mar 30, 2026

SHE:002873 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
749.72856.87953.261,087968.7
Other Revenue
-0.670.730.881.15
749.72857.55953.981,088969.84
Revenue Growth (YoY)
-12.57%-10.11%-12.29%12.15%29.15%
Cost of Revenue
213.07230.72219.39247.65201.16
Gross Profit
536.65626.83734.59840.02768.69
Selling, General & Admin
456.71513.64589.02673.99606.18
Research & Development
42.5540.4738.1321.5820.38
Other Operating Expenses
7.271210.5413.1713.81
Operating Expenses
506.53568.72637.42709.27642.1
Operating Income
30.1258.1197.17130.75126.58
Interest Expense
--17.57-11.8-10.67-16.6
Interest & Investment Income
0.010.670.920.731.37
Currency Exchange Gain (Loss)
--0--
Other Non Operating Income (Expenses)
-15.95-0.051.92-5.41-2.93
EBT Excluding Unusual Items
14.1741.1688.21115.39108.42
Gain (Loss) on Sale of Investments
-0.020.02-0.72-0.4-
Gain (Loss) on Sale of Assets
-0.7818.9--0.02-0.1
Asset Writedown
-3.6-0.71-0.07-0.12-0.37
Other Unusual Items
-1.3856.488.69
Pretax Income
9.7760.7692.42121.34116.65
Income Tax Expense
0.668.4311.559.8316.04
Earnings From Continuing Operations
9.1152.3280.87111.52100.61
Net Income
9.1152.3280.87111.52100.61
Net Income to Common
9.1152.3280.87111.52100.61
Net Income Growth
-82.59%-35.30%-27.48%10.85%35.76%
Shares Outstanding (Basic)
235220232232227
Shares Outstanding (Diluted)
235220245244245
Shares Change (YoY)
6.87%-9.91%0.41%-0.41%1.34%
EPS (Basic)
0.040.240.350.480.44
EPS (Diluted)
0.040.240.330.460.41
EPS Growth
-83.70%-28.18%-27.78%11.30%33.96%
Free Cash Flow
32.1426.68-23.92-53.3818.61
Free Cash Flow Per Share
0.140.12-0.10-0.220.08
Dividend Per Share
-0.1000.0700.1000.086
Dividend Growth
-42.86%-30.00%16.69%40.03%
Gross Margin
71.58%73.10%77.00%77.23%79.26%
Operating Margin
4.02%6.78%10.19%12.02%13.05%
Profit Margin
1.21%6.10%8.48%10.25%10.37%
Free Cash Flow Margin
4.29%3.11%-2.51%-4.91%1.92%
EBITDA
64.7589.14117.51155.38148.33
EBITDA Margin
8.64%10.39%12.32%14.29%15.29%
D&A For EBITDA
34.6331.0420.3424.6421.74
EBIT
30.1258.1197.17130.75126.58
EBIT Margin
4.02%6.78%10.19%12.02%13.05%
Effective Tax Rate
6.73%13.88%12.49%8.10%13.75%
Revenue as Reported
-857.55953.981,088969.84
Advertising Expenses
-16.5743.4643.15-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.